# Use of Telemonitoring to Facilitate Heart Failure Medication Titration

Study · id `cardio:ct-nct04205513` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04205513](<https://clinicaltrials.gov/study/NCT04205513>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04205513

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 108 participants.

## Technical summary

Registry record NCT04205513. Randomized; no masking; primary purpose treatment. Start 2019-01-01 (actual); primary completion 2022-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 108 participants (planned count; ClinicalTrials.gov record NCT04205513, source copy `cardio:ctgov-nct04205513-2024-03-19`, retrieved 2026-10-26)
- Started: 2019-01-01 (actual) (ClinicalTrials.gov record NCT04205513, source copy `cardio:ctgov-nct04205513-2024-03-19`, retrieved 2026-10-26)
- Primary completion: 2022-12-31 (actual) (ClinicalTrials.gov record NCT04205513, source copy `cardio:ctgov-nct04205513-2024-03-19`, retrieved 2026-10-26)
- Completion: 2024-12-31 (anticipated) (ClinicalTrials.gov record NCT04205513, source copy `cardio:ctgov-nct04205513-2024-03-19`, retrieved 2026-10-26)
- Countries: Canada (ClinicalTrials.gov record NCT04205513, source copy `cardio:ctgov-nct04205513-2024-03-19`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04205513-2024-03-19`, retrieved 2026-10-26)

## The registry's words

- Brief title: Use of Telemonitoring to Facilitate Heart Failure Medication Titration
- Acronym: Medly Titrate
- Condition: Heart Failure
- Intervention (Device): Medly
- Lead sponsor: University Health Network, Toronto
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: University Health Network, Toronto (`cardio:org-university-health-network-toronto`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The Effect of Using a Remote Patient Management Platform in Optimizing Guideline-Directed Medical Therapy in Heart Failure Patients: A Randomized Controlled Trial (`cardio:pubmed-38569821`)
- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Carbon and Travel Cost Reduction From Remote Medication Titration for Advanced Heart Failure: A Secondary Analysis of a Randomized Controlled Trial (`cardio:pubmed-40744126`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 81d26c6e2fb3c5e24e594cb2f90f08ad9c86fe5c10d17eaaa12e79b6581111fb
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
